Healthcare Industry Resilience Collaborative (HIRC) Awards Gold Level Resiliency Badge to Baxter International Inc. (BAX)

With significant upside potential, Baxter International Inc. (NYSE:BAX), secures a spot on our list of the 12 Best Widow and Orphan Stocks to Buy According to Analysts.

On September 26, 2025, Baxter International Inc. (NYSE:BAX), a leading global medtech company, was awarded a Gold Level Resiliency Badge by the Healthcare Industry Resilience Collaborative (HIRC) across IV Solutions, Nutrition Solutions, and Premix Drugs. This marks the first time a manufacturer has been recognized at this level across these categories, reflecting Baxter’s efforts to strengthen healthcare supply chain resilience.

The recognition followed HIRC’s comprehensive review of Baxter International Inc. (NYSE:BAX)’s resilience measures, including proactive inventory management, enhanced risk forecasting, robust cybersecurity frameworks, and real-time logistical visibility through its Control Tower system. The award builds on Baxter’s previous Transparency Badges in 2023 and 2024, as well as its launch of the Welch Allyn Connex 360 Vital Signs Monitor earlier this month, which expanded its connected monitoring product line.

Baxter International Inc. (NYSE:BAX) operates through its Pharmaceuticals, Healthcare Systems and Technologies, and Medical Products and Therapies divisions, offering a wide range of healthcare products in the U.S. and worldwide. It is one of the Best Widow and Orphan Stocks.

While we acknowledge the potential of BAX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 15 Stocks That Will Benefit From AI and 12 Best Quantum Computing Stocks to Buy According to Wall Street Analysts.

Disclosure: None.